Synavant Sells Pharmaceutical DM Unit

Share this article:
The French firm Groupe Cegedim purchased the direct marketing arm of Atlanta-based pharmaceutical marketer Synavant for $43.5 million, the companies said Sunday.


Synavant said it decided that its direct marketing business unit was no longer part of its core business strategy. The DM unit generated $50 million in revenue in the 12 months ending in September 2002.


Proceeds of the sales will be given to shareholders, Synavant said, though the form of the transfer has yet to be decided. Synavant also said it would review its other business units and decide whether to invest more resources in them or consider other transactions.


The purchase expands Groupe Cegedim's presence in North America. Groupe Cegedim also specializes in pharmaceutical marketing.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

Customer Centricity Is Spurring Marketing-Tech Investments

Customer Centricity Is Spurring Marketing-Tech Investments

A majority of marketers rank customer satisfaction improvements as paramount in the technology investment decisions.

Big, Bold Moves in the C-Suite

Big, Bold Moves in the C-Suite ...

JCPenney appoints Home Depot's Marvin Ellison as CEO; Harte Hanks and JWT add hitting power to their C-level benches

Campaign Comes to the States

Campaign Comes to the States

DMN's UK-based sister publication launches Campaign US